Company intelligence / Profile preview

RTW Investments

New York, New York, United Statesrtwfunds.com ↗

Ownership: Private
Development stage: Other

Overview

RTW Investments is a leading life science investment and innovation firm supporting breakthrough therapies across all stages of development. It has enabled positive clinical results through its portfolio companies—recent examples include Artios Pharma’s ART0380 showing promising Phase 1/2a data in oncology.

Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateGene therapy
Industry: Investors

Partnerships

Major partnerships occur at the level of their investee or incubated companies with large pharma partners like Johnson & Johnson via transactions involving assets such as bi-specific antibodies from Numab Therapeutics AG's subsidiary Yellow Jersey Therapeutics

Beyond the preview

Go deeper on RTW Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RTW Investments.